New drug aims to shield patients from chemo side effects in bladder cancer battle
Disease control
Not yet recruiting
This early-stage study is testing whether adding an investigational drug called GB-4362 to a standard two-drug regimen can make treatment safer for adults with advanced bladder cancer. GB-4362 is designed to neutralize a specific chemotherapy component that causes side effects li…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC